TLR Activation Induces TNF- Production from Adult Neural
Stem/Progenitor Cells
1
Ruxandra Covacu,
2
* Lisa Arvidsson,
†
Åsa Andersson,* Mohsen Khademi,*
Helena Erlandsson-Harris,
‡
Robert A. Harris,* Mikael A. Svensson,
†
Tomas Olsson,*
and Lou Brundin*
Adult neural stem cells (NSCs) are believed to facilitate CNS repair and tissue regeneration. However, it is not yet clear how these
cells are influenced when the cellular environment is modified during neurotrauma or neuroinflammatory conditions. In this study,
we determine how different proinflammatory cytokines modulate the expression of TLR2 and TLR4 in NSCs and how these cells
respond to TLR2 and TLR4 agonists. Primary cultures of neural stem/progenitor cells isolated from the subventricular zone of
brains from adult Dark Agouti rats were exposed to 1) supernatants from activated macrophages; 2) proinflammatory cytokines
IFN-, TNF-, or both; and 3) agonists for TLR2 and TLR4. Both TLR2 and TLR4 were expressed during basal conditions and
their mRNA levels were further increased following cytokine exposure. TLR4 was up-regulated by IFN- and this effect was
reversed by TNF-. TLR2 expression was increased by supernatants from activated macrophages and by TNF-, which syner-
gized with IFN-. TLR agonists induced the expression of TNF- mRNA. Importantly, TNF- could be translated into protein
and released into the supernatants where it was quantified by cytokine ELISA. In conclusion, we demonstrate that NSCs con-
stitutively express TLR2 and TLR4 and that their expression is increased as a consequence of exposure to proinflammatory
mediators. Additionally, activation of these receptors can induce production of proinflammatory cytokines. These findings suggest
that NSCs may be primed to participate in cytokine production during neuroinflammatory or traumatic conditions. The Journal
of Immunology, 2009, 182: 6889 – 6895.
T
he ability of adult neural stem cells (NSCs)
3
to respond to
trauma to the CNS by migration and differentiation at the
site of injury has been demonstrated in numerous studies
in various disease models (1– 4). However, the role of NSCs in
neuroinflammatory lesions is not entirely clear. It has become ev-
ident during recent years that these cells are not only a source of
newly generated cells but may also supply trophic support to cells
in the damaged CNS (5, 6). Moreover, in experimental autoim-
mune encephalomyelitis (EAE), an animal model of multiple scle-
rosis (MS), NSCs have immunomodulatory effects (7, 8) and are
induced to express immune markers characteristic of APCs (9).
The focus of this project is to 1) investigate the expression of the
TLR2 and TLR4 on NSC/progenitor cells, both under normal and
inflammatory conditions and 2) monitor the effects of TLR2 and
TLR4 activation in NSC/progenitor cells.
TLRs are pattern recognition receptors characteristic of immune
cells and are crucial for inducing an immune response to patho-
gens. Interestingly, Toll was first described in Drosophila to be
involved in neural development (10, 11), and in mammals TLRs
are involved in differentiation of different stem cell populations,
such as hematopoietic stem cells (12–14) and mesenchymal stem
cells (15). There are 13 TLRs described in mice and 10 in humans,
and the best-described TLRs are TLR2 and TLR4. TLR2 associ-
ates with either TLR1 (16) or TLR6 (17) and binds lipoproteins
and lipopeptides. TLR4 binds to LPS (18, 19). In addition, all
receptors have endogenous ligands (20 –23) that are released from
damaged tissues, and there is available evidence suggesting that
TLR2 and TLR4 may be involved in the disease development dur-
ing EAE and MS (24 –27). Neuroinflammatory conditions, such as
MS and EAE, are characterized by infiltration of immune cells into
the CNS and production of proinflammatory agents such as NO,
TNF-, and IFN-, which in turn contribute to destruction of CNS
tissue. The most predominant location of the inflammatory lesions
in MS is close to the regenerative area of the subventricular zone
(SVZ) where NSCs reside. NSCs can therefore be directly influ-
enced by the inflammatory process.
In this study, we demonstrate evidence for TLR2 and TLR4
expression on NSCs both in vitro and in vivo. The expression of
these receptors was transcriptionally up-regulated as a conse-
quence to inflammatory exposure. The expression of TLR2 and
TLR4 was differentially affected by the two major proinflamma-
tory cytokines evident in EAE and MS, TNF- and IFN-. IFN-
favored induction of TLR4. TNF- induced the expression of
TLR2 and abrogated the inducing effect of IFN- on TLR4 ex-
pression. Moreover, the expression of TLR2 was up-regulated fol-
lowing exposure to supernatants from activated macrophages.
Most importantly, NSCs exposed to TLR2 and TLR4 agonists
produced and released TNF- protein. We thus demonstrate that
*Department of Clinical Neurosciences, Division of Neuroimmunology,
†
Department
of Neurosurgery, and
‡
Department of Medicine, Division of Rheumatology, Karolin-
ska Institutet, Stockholm, Sweden
Received for publication September 2, 2008. Accepted for publication March
24, 2009.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked advertisement in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
1
This work was supported by Torsten and Ragnar So ¨derberg Foundation, Montel
Williams Foundation, The Swedish Society for Neurologically Disabled, and Karo-
linska Institutet.
2
Address correspondence and reprint requests to Dr. Ruxandra Covacu, Karolinska
Hospital, Center for Molecular Medicine, L8-04, Neuroimmunology Unit, Karolinska
Institutet, S-171 76 Stockholm, Sweden. E-mail address: Ruxandra.Covacu@ki.se
3
Abbreviations used in this paper: NSC, neural stem cell; EAE, experimental auto-
immune encephalomyelitis; MS, multiple sclerosis; LTA, lipoteichoic acid; SVZ,
subventricular zone; GFAP, glial fibrillary acidic protein.
Copyright © 2009 by The American Association of Immunologists, Inc. 0022-1767/09/$2.00
The Journal of Immunology
www.jimmunol.org/cgi/doi/10.4049/jimmunol.0802907